Skip to main content
. 2020 Dec 15;21(24):9531. doi: 10.3390/ijms21249531
CAR Chimeric antigen receptor
ITIM immune tyrosine-based inhibitory motif
MAC membrane attacking complex
FcγR Fc-gamma receptor
ITAM immune tyrosine-based activation motif
mAbs monoclonal antibodies
NHL non-Hodgkin lymphoma
CLL chronic lymphocytic leukemia
CTCL cutaneous T cell lymphoma
PTCL peripheral T cell lymphoma
NK natural killer
DCs dendritic cells
TM4SF transmembrane-four superfamily proteins
TEM tetraspanin-enriched membrane microdomain
CXCL chemokine (C-X-C motif) ligand
APC antigen-presenting cell
MHC major histocompatibility complex
TCR T cell receptor
BCR B cell receptor
VCAM-1 vascular cell adhesion molecule-1
EV extracellular vesicles
SOCS3 suppressor of cytokine signaling 3
Bcl-2 B cell lymphoma 2
R-CHOP rituximab+chemotherapy
DLBCL diffuse large B cell lymphoma
IPI International Prognostic Index
PKC protein kinase C
Jak Janus Kinase
STAT3 Signal Transducer and Activator of Transcription 3
PI3K phosphatidylinositol 3-kinase
NF-κB nuclear factor kappa-light-chain-enhancer of activated B cells
FoxO3a Forkhead box O3
GSK3 glycogen synthase kinase 3
AML acute myeloid leukemia
NSCLC non-small cell lung cancer
IL interleukin
IgG Immunoglobulin G
SHP-1 Src homology region 2 domain-containing phosphatase-1
IL-7R interleukin-7 receptor
CDC complement-dependent cytotoxicity
ADCC antibody-dependent cellular cytotoxicity
ADCP antibody-dependent cellular phagocytosis
PDX patient derived xenografts
scFv single-chain variable fragment
MCL mantle cell lymphoma